Back
Aardvark Therapeutics Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21
AARD
Aardvark Therapeutics
Last Price:
$7.84
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aardvark Therapeutics Stock Forecast
-
Is Aardvark Therapeutics Stock Undervalued?The current Aardvark Therapeutics [AARD] share price is $7.17. The Score for AARD is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
AARD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Aardvark Therapeutics Stock Go Up Next Year?
Data Unavailable
Aardvark Therapeutics Stock Rating
Data Unavailable
Aardvark Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
aardvarktherapeutics.com
52-Week Data
52-Week High:
19.58
52-Week Low:
6.79
Prediction Charts
Market Cap:
170.1M
Price in USD:
7.17
Volume:
145.5K
Beta:
0.00
Technical Analysis
SMA50:
0.00
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%
Stock Predictions
-
Is Aardvark Therapeutics stock public?Yes, Aardvark Therapeutics is a publicly traded company.
-
What is the Aardvark Therapeutics stock quote today?The Aardvark Therapeutics stock price is 7.17 USD today.
-
How to buy Aardvark Therapeutics stock online?You can buy Aardvark Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-20 | 9.48 | 9.18 | 9.68 | 8.60 |
| Mar-21 | 9.30 | 9.93 | 10.10 | 9.30 |
| Mar-24 | 9.91 | 9.24 | 10.00 | 9.14 |
| Mar-25 | 9.32 | 9.09 | 9.47 | 8.69 |
| Mar-26 | 8.90 | 9.42 | 9.55 | 8.70 |
| Mar-27 | 10.28 | 8.90 | 10.38 | 8.58 |
| Mar-28 | 8.71 | 7.74 | 9.16 | 7.74 |
| Mar-31 | 7.46 | 7.51 | 7.90 | 6.79 |
| Apr-1 | 7.50 | 8.29 | 9.70 | 7.50 |
| Apr-2 | 8.39 | 9.35 | 9.42 | 8.01 |
| Apr-3 | 9.15 | 8.62 | 9.19 | 8.34 |
| Apr-4 | 8.23 | 8.16 | 8.84 | 7.60 |
| Apr-7 | 8.27 | 7.94 | 8.27 | 7.23 |
| Apr-8 | 8.07 | 7.17 | 8.30 | 7.01 |
Aardvark Therapeutics Earnings
Data Unavailable
Aardvark Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.96 per share, and an increase next year of $0.13 per share.
* Aardvark Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.